although
viral
variant
recogn
epitopespecif
cytotox
lymphocyt
ctl
shown
lo
aris
number
persist
viru
infect
mani
case
signific
remain
controversi
argu
immun
respons
suffici
plastic
contain
replic
review
describ
mechan
amino
acid
chang
viral
protein
may
affect
epitop
recognit
virusspecif
ctl
discuss
viral
immunolog
basi
emerg
viral
variant
bear
amino
acid
chang
infect
consid
impact
viral
variat
may
host
ctl
respons
abil
contain
viru
replic
argu
emerg
viral
variant
demonstr
must
vivo
replic
advantag
variant
must
tip
balanc
viru
replic
immun
control
somewhat
favor
viru
suggest
although
immun
respons
evolv
recogn
new
viral
epitop
ctl
gener
follow
evolut
frequent
reduc
abihti
contain
viru
replic
conclud
escap
mechan
like
make
signific
contribut
persislencepathogenesi
number
diftereni
viru
infect
follow
viru
infect
seri
complex
interact
occur
viru
host
immun
system
host
aim
ehmin
infect
minim
associ
patholog
consequ
whilst
viru
tri
avoid
clearanc
host
immun
respons
persist
dissemin
host
long
time
period
virus
evolv
varieti
differ
strategi
avoid
clearanc
host
immun
respons
singl
viru
often
employ
multipl
strategi
simultan
increas
chanc
persist
face
adapt
host
defens
system
array
differ
effector
mechan
cellmedi
immim
respons
particular
virusspecif
cytotox
tlymphocyt
ctl
respons
frequent
play
key
role
ehmin
establish
viru
infect
mani
viral
evas
strategi
target
arm
immun
respons
viral
immun
evas
strategi
may
broadli
divid
two
categori
enabl
viru
avoid
detecjrrow
shaw
vivo
import
ctl
escap
virus
tion
host
immun
respons
impair
function
host
immun
system
viral
impair
function
host
immun
system
may
nonantigenspecif
exemplifi
product
homolog
host
cytokin
rheir
receptor
mimic
case
immun
downregulatori
block
case
immunestimulatori
antivir
effector
action
host
cytokin
hy
infect
cell
immun
system
caus
either
impair
function
result
destruct
latter
may
occur
either
directli
hy
cell
render
target
immun
lysi
howev
sever
gener
impair
host
immun
function
lead
death
host
thu
reduc
opportun
viru
spread
prefer
strategi
impair
virusspecif
immun
respons
exampl
may
achiev
virus
infect
target
destruct
antigenspecif
b
cell
induc
exhaust
highaffm
clone
virusspecif
cell
strategi
virus
may
employ
avoid
detect
hy
host
immun
respons
includ
establish
latent
infect
vhich
viral
protein
product
minim
strategi
commonli
employ
hy
herpesvirus
perfect
herp
simplex
viru
ii
infect
immuneprivileg
site
access
immun
system
restrict
level
major
histocompat
complex
mhc
antigen
express
iow
immun
downregulatori
mediat
may
present
best
exampl
hrain
surprisingli
larg
number
differ
virus
persist
iii
virusinduc
downregul
level
mhc
antigen
adhes
molecul
surfac
infect
cell
hat
trigger
host
tcell
recognit
iv
evolut
antigen
variant
whose
recognit
specif
immun
respons
impair
antigen
variat
initi
document
mean
viral
escap
antibodi
neutrahz
recent
also
heen
shown
confer
viral
escap
ctl
control
although
immun
evas
mechan
potenti
promot
viral
persist
contribut
mechan
fact
make
persist
vivo
particularli
human
viru
infect
complet
dear
exampl
although
viral
variant
recogn
epitopespecif
ctl
bave
found
number
persist
viru
infect
mani
case
signific
remain
controversi
heen
argu
immun
respons
suffici
plastic
contain
rephcat
review
mechan
hy
amino
acid
chang
viral
protein
may
affect
epitop
recognit
virusspecif
ctl
describ
viral
immunoiog
basi
emerg
viral
variant
bear
amino
acid
chang
infect
discuss
impact
viral
variat
may
antivir
ctl
respons
cours
viru
infect
consid
contrihut
escap
mechan
may
make
persistencepathogenesi
differ
viru
infect
discuss
mechan
amino
acid
chang
may
affect
epitop
recognit
virusspecif
ctl
viral
epitop
recogn
cell
must
process
present
cell
surfac
associ
mhc
class
molecul
amino
acid
chang
may
thu
affect
epitop
recognit
specif
cell
hy
alter
step
involv
pathway
initi
gener
epitop
peptid
format
stabl
complex
mhc
may
cours
also
affect
interact
peptidemhc
complex
tcell
receptor
tcr
either
ablat
tcr
bind
altogeth
alter
signahng
occur
via
tcr
describ
exampl
found
amino
acid
chang
viral
protein
act
via
mechan
alter
ofantigen
processingpeptid
transport
effici
process
present
ctl
epitop
determin
sequenc
epitop
also
residu
surround
protein
amino
acid
mutat
flank
sequenc
may
thu
affect
recognit
viral
ctl
epitop
origin
demonstr
experi
use
cytomegaloviru
influenza
virusspecif
ctl
precis
mechan
antigen
process
affect
defm
studi
subsequ
paper
describ
mutat
nef
protein
human
immunodefici
viru
type
also
affect
present
nearbi
ctl
epitop
howev
recent
report
alter
proteasomemedi
degrad
due
singl
amino
acid
differ
within
ctl
epitop
shown
form
basi
lack
present
epitop
infect
cell
mice
infect
akvmcf
type
murin
leukemia
viru
epitop
pi
transmembran
viral
envelop
protein
constitut
immunodomin
sequenc
recogn
virusspecif
ctl
ctl
recogn
cell
infect
friendmoloneyrausch
type
murin
leukemia
viru
epitop
sequenc
differ
singl
residu
amino
acid
differ
caus
epitop
destruct
specif
proteasom
cleavag
mice
infect
latter
viru
thu
mount
ctl
respons
epitop
amino
acid
chang
alter
process
ctl
epitop
therefor
dramat
effect
vivo
antivir
ctl
respons
unclear
commonli
mutat
select
persist
viru
infect
rel
exampl
amino
acid
chang
viral
protein
affect
ctl
recognit
via
mechan
describ
could
reflect
fact
mutat
readili
pick
method
frequent
use
analyz
antivir
ctl
respons
altern
requir
antigen
processingpeptid
transport
may
much
less
stringent
peptid
interact
mhc
tcel
receptor
amino
acid
chang
affect
former
aris
less
often
amino
acid
mutat
within
epitop
peptid
may
ablat
peptid
bind
mhc
altogeth
reduc
affmiti
peptidemhc
interact
peptidemhc
complex
extrem
short
halfhf
unlik
trigger
tcell
activ
viral
mutat
alter
peptid
interact
mhc
class
molecul
way
describ
exampl
hiv
recent
review
mutat
prevent
stabl
associ
peptid
mhc
confer
escap
recognit
epitopespecif
cell
regardless
tcr
usag
effici
mechan
virus
avoid
ctl
recognit
interest
human
leukocyt
antigen
hla
epitop
loss
epsteinbarr
viru
ebv
isol
deriv
popul
frequenc
hlaal
extrem
high
confer
via
mutat
anchor
residu
epitop
import
bind
hlaal
ebv
genet
stabl
dna
viru
gener
mutant
rel
low
frequenc
mutant
thu
come
prevail
popul
confer
advantag
spread
viru
new
host
differ
tcr
may
use
recogn
peptidemhc
complex
mutat
ablat
bind
immunodomin
restrict
ebv
ctl
epitop
mhc
allow
escap
recognit
epitopespecif
cell
host
alter
peptid
interact
tcr
amino
acid
chang
peptid
prevent
present
associ
mhc
may
result
alter
surfac
recogn
tcr
surfac
may
alter
chang
tcr
contact
residu
chang
residu
epitop
caus
peptid
bind
mhc
distort
conform
epitop
bear
mutat
caus
alter
tcr
contact
surfac
term
alter
peptid
ligand
apl
epitopespecif
cell
bear
distinct
tcr
may
affect
apl
differ
way
alter
peptidemhc
complex
may
fail
interact
particular
tcr
altogeth
may
recogn
cell
may
receiv
reduc
even
differ
type
signal
recogn
aplbear
cell
respond
cell
may
thu
partli
activ
eg
prolifer
induc
cell
lysi
even
anerg
present
certain
apl
cell
therefor
inhibit
respons
index
peptid
compet
bind
mhc
neg
signal
respond
tcell
popul
phenomenon
known
tcell
antagon
abihti
apl
act
ctl
antagonist
test
measur
capac
cell
present
apl
inhibit
lysi
label
target
cell
present
index
peptid
use
techniqu
mutat
confer
antagonist
properti
epitop
sequenc
shown
exist
persist
viru
popul
individu
chronic
infect
hepat
b
viru
hbv
although
viral
mutat
result
gener
apl
may
provid
effici
mean
simpl
escap
immun
recognit
mutat
abrog
epitop
present
altogeth
apl
may
still
immunogen
proport
host
cell
could
expand
follow
emerg
mutant
could
potenti
power
effect
overal
control
viru
replic
via
mechan
abl
act
tcell
antagonist
may
inhibit
lysi
cell
mutant
epitop
present
also
cell
nonmut
viru
replic
henc
confer
protect
immun
control
entir
viral
quasispeci
apl
abl
stimul
sustain
growth
ctl
despit
fact
induc
ctl
lysi
could
drive
ineffectu
ctl
respons
henc
modul
ctl
repertoir
detriment
fashion
reduc
overal
effici
ctl
control
viru
replic
genet
variat
strategi
virus
exploit
promot
surviv
face
host
immun
respons
environment
condit
may
encount
achiev
variat
number
differ
mechan
includ
mutat
homolog
nonhomolog
recombin
virus
segment
genom
reassort
differ
virn
famili
utihz
differ
extent
rna
virus
includ
retrovirus
dna
virus
immtinologicd
review
bepadnavirus
whose
genom
replic
involv
rna
intermedi
extrem
high
mutat
rate
due
larg
part
absenc
low
effici
proofreadingrepair
activ
associ
rna
replicas
transcriptas
lack
postrephc
error
correct
mechan
diat
normal
oper
rephcat
cellular
dna
misinsert
error
rna
rephcat
revers
transcript
estim
rang
substitut
per
nucleotid
per
round
copi
kb
genom
w
mld
result
progeni
rna
strand
includ
averag
mutat
rna
virus
thu
exist
homogen
popul
complex
dynam
mixtur
heterogen
sequenc
term
quasispeci
viru
replic
constant
set
environment
condit
optim
adapt
although
precis
composit
quasispeci
continu
fluctuat
averag
sequenc
viral
popul
remain
unchang
howev
condit
alter
mutat
confer
increas
fit
rel
abil
viru
produc
infecti
progeni
select
come
predomin
viral
popul
quasispeci
natur
rna
virus
conpl
short
replic
time
high
viral
yield
frequent
exhibit
favor
rapid
adapt
environment
chang
dramat
exampl
viral
evolut
respons
environment
pressur
provid
emerg
drugresist
viral
variant
patient
treat
antiretrovir
agent
eg
hiv
retroviru
vivo
mutat
rate
approxim
nucleotid
per
rephcat
cycl
human
infect
virn
character
high
level
persist
viru
much
activ
replic
turn
remark
rate
mani
virion
may
produc
per
day
allow
great
potenti
variat
although
infecti
effect
popul
size
may
much
smaller
singl
nucleotid
chang
suffici
confer
high
level
resist
antiretrovir
treatment
resist
may
select
rapidli
eor
exampl
singl
nucleotid
chang
reduc
hiv
susceptibihti
nonnucleosid
revers
transcriptas
inhibitor
nevirapin
viral
variant
bear
mutat
shown
preexist
plasma
hiv
rna
untreat
patient
patient
high
level
resist
drug
may
acquir
within
week
start
therapi
case
multipl
mutat
requir
achiev
drug
resist
either
seri
mutat
need
occur
high
level
resist
one
antiretrovirai
agent
achiev
patient
treat
simultan
combin
sever
antiretrovir
agent
take
longer
resist
evolv
inde
patient
particularli
viru
replic
reduc
low
level
may
howev
observ
illustr
tremend
potenti
rna
virus
overcom
control
forc
cours
infect
via
select
resistanceconf
mutat
condit
ctl
escap
viral
variant
select
vivol
outlin
mutat
select
viru
popul
allow
number
predict
made
vivo
condit
ctl
escap
virn
variant
like
emerg
firstli
mutat
select
confer
fit
advantag
viru
hear
ctl
escap
viru
variant
grow
infect
ctl
pressur
exert
signific
control
viru
replic
thu
perhap
surpris
first
report
vivo
emerg
ctl
escap
viru
variant
came
studi
perform
use
lymphocyt
choriomening
viru
lcmv
murin
viru
infect
lcmv
ctl
respons
well
known
critic
determin
control
viru
rephcat
review
convers
demonstr
viral
variant
bear
mutat
confer
escap
cell
come
domin
viral
quasispeci
particular
viru
infect
use
provid
evid
import
arm
immun
respons
control
infect
human
viru
infect
may
otherwis
difficult
demonstr
convincingli
secondli
stronger
control
viru
rephcat
exert
ctl
respons
direct
particular
epitop
greater
select
pressur
exert
escap
mutat
epitop
emerg
viral
popul
frequenc
ctl
direct
particular
epitop
avid
target
cell
interact
clearli
influenc
select
escap
mutat
epitop
origin
demonstr
ctl
escap
viru
select
lcmv
system
actual
made
tcr
transgen
mice
cell
specif
epitop
escap
mutat
observ
made
peripher
tcell
popul
prior
infect
artifici
system
howev
due
advanc
method
quantit
epitopespecif
cell
recent
becom
appar
epitopespecif
cell
reach
extrem
high
frequenc
natur
viru
infect
mice
human
particularli
primari
immun
respons
primari
infect
thu
clearli
set
escapeconf
mutat
may
potenti
emerg
rapidli
although
lower
frequenc
epitopespecif
ctl
also
capac
drive
select
escap
viral
variant
select
occur
gradual
cours
greater
number
round
viral
rephcat
greater
select
advantag
confer
hy
particular
viral
mutat
faster
mutat
select
viral
quasispeci
thu
strength
ctl
respons
particular
epitop
hut
also
immunodomin
respons
great
impact
likelihood
escap
mutat
select
within
epitop
escap
mutat
subdomin
even
codomin
ctl
epitop
may
confer
shght
select
advantag
viral
variant
bear
whose
replic
still
control
domin
codomin
ctl
respons
host
may
never
emerg
vivo
viru
rephcat
must
clearli
ongo
viral
variant
gener
select
particularli
select
advantag
confer
certain
amino
acid
mutat
great
mani
cycl
viru
replic
may
need
occur
virus
bear
becom
predomin
viral
quasispeci
domin
ctl
respons
certain
viral
epitop
overal
control
viru
replic
thu
also
import
determin
emerg
escap
mutat
epitop
sequenc
perspect
arm
immun
respons
tcell
respons
epitop
viru
affect
mutat
concern
abl
reduc
viru
replic
low
level
mediat
viral
clearanc
escap
mutat
time
hecom
fix
viral
popul
cours
infect
ctl
escap
viru
variant
thu
like
emerg
face
host
ctl
respons
highli
domin
cell
singl
epitop
specif
even
strong
respons
particular
epitop
unhk
chanc
select
escap
viral
variant
context
strong
respons
epitop
illustr
observ
made
murin
lcmv
infect
model
ctl
respons
moant
lcmv
infect
mice
broad
epitop
specif
viral
glycoprotein
gp
nucleoprotein
ne
alon
least
five
differ
ctl
epitop
heen
identifi
although
respons
epitop
extrem
strong
cell
recogn
epitop
ne
constitut
tcell
popul
recogn
epitop
ge
peak
antivir
immun
respons
infect
rapidli
clear
ctl
escap
viral
variant
emerg
mice
immun
one
epitop
carrier
protein
prior
infect
ctl
respons
mount
upon
lcmv
infect
bias
favor
epitop
viral
clearanc
still
occur
howev
viru
isol
mice
prior
clearanc
grown
vitro
found
contain
escap
mutat
epitop
ctl
respons
bias
escap
viral
variant
thu
aris
context
immunodomin
ctl
respons
grow
vivo
infect
clear
rapidli
lcmv
tcr
transgen
mice
discuss
repres
situat
epitop
immunodomin
extrem
spectrum
tcell
repertoir
domin
transgeneexpress
cell
recogn
lcmv
ge
epitop
ctl
respons
effect
mount
viral
epitop
thu
infect
lcmv
viral
mutant
aris
recogn
ge
specif
ctl
replic
contain
ctl
specif
emerg
context
viral
persist
ahov
predict
ctl
escap
viral
variant
like
emerg
context
strong
host
ctl
respons
highli
focus
singl
viral
epitop
support
observ
one
clearest
exampl
emerg
ctl
escap
viru
variant
human
viru
infect
occur
condit
other
shown
strong
ctl
respons
mount
earli
follow
infect
prior
seroconvers
hypothes
play
import
role
contain
viral
replic
one
patient
studi
earli
ctl
respons
day
follow
onset
symptom
indic
acut
infect
occur
day
homosexu
encount
initi
contract
viru
appear
strongli
direct
singl
viral
protein
epitop
map
perform
use
gpl
sequenc
patient
autolog
earli
popul
indic
respons
fact
extrem
focus
singl
epitop
encompass
amino
acid
recogn
associ
frequenc
epitopespecif
ctl
extrem
high
earhest
timepoint
avail
studi
may
shghtli
peak
primari
immun
respons
peripher
blood
mononuclear
cell
ebmc
found
score
virusspecif
ctl
precursor
limit
dilut
analysi
techniqu
recent
shown
greatli
underestim
total
numher
epitopespecif
cell
shown
fig
viral
variant
bear
mutat
epitop
sequenc
confer
escap
recognit
epitopespecif
ctl
rapidli
appear
patienc
increas
frequenc
cotnpieteiy
repiac
transmit
virai
strain
interestingli
variant
came
predomin
virai
quasispeci
aii
possess
chang
gpi
amino
acid
posit
constitut
major
anchor
residu
discuss
mutat
abiat
peptid
bind
mhc
confer
escap
recognit
aii
epitopespecif
ceii
inde
oniy
individu
ctl
cion
aiso
bulk
ctl
deriv
patient
unabi
recogn
peptid
correspond
mutant
viru
sequenc
vitto
assay
fig
thu
human
murin
systetn
evid
mutat
confer
resist
controi
epitopespecif
ctl
iiiieiy
seiect
highiy
immunodomin
epitop
condit
epitop
immunodomin
singi
mutat
provid
escap
recognit
ctl
one
specif
wiii
confer
greater
repiic
advantag
mutant
viru
thu
seiection
wiii
stronger
piu
wiii
greater
chanc
viru
replic
wiii
abi
continu
iong
enough
mutat
compieteiy
repiac
index
residu
virai
quasispeci
evolut
ctl
profil
respons
emerg
escap
viral
variant
virai
quasispeci
ciearli
evoiv
respons
host
immun
pressur
host
immun
respons
aiso
adapt
turn
evoiv
respons
emerg
escap
viral
variant
specif
immun
respons
nltimat
driven
antigen
emerg
ctl
escap
mutat
viru
popul
conrs
infect
could
potenti
affect
antigen
wbicb
tbe
immun
system
expos
henc
ctl
profil
sever
way
firstli
unless
mutat
select
affect
ctl
stimul
effector
function
diminish
level
ctl
specif
index
epitop
declin
level
ofantigen
avail
stimul
decreas
secondli
mutant
sequenc
present
stimnlat
novel
popul
host
ctl
increas
frequenc
thirdli
mutat
reduc
effici
epitop
present
may
allow
level
present
viral
epitop
increas
henc
ctl
differ
specif
increas
frequenc
novel
popul
host
ctl
stimul
final
tbe
mutant
viru
must
bave
rephc
advantag
tbe
origin
viru
order
select
antigen
load
increas
drive
overal
expans
virusspecif
ctl
discuss
earlier
ctl
escap
mutat
like
select
immunodomin
ctl
epitop
end
result
effect
breadth
tbe
ctl
respons
increas
previous
domin
tcell
clone
declin
frequenc
subdomin
novel
respons
stimul
sucb
broaden
ctl
specif
respons
tbe
emerg
viral
variant
abl
escap
recognit
ctl
direct
highli
immunodomin
epitop
appar
hiv
patient
describ
previou
section
illustr
fig
wherea
pbmc
deriv
tbe
patient
earli
tbe
infect
mediat
detect
lysi
vitro
restimul
target
cell
express
immunodomin
epitop
viral
variant
bear
mutat
epitop
emerg
respons
epitop
elsewher
viral
protein
becam
appar
declin
frequenc
ofctl
direct
gpl
epitop
occur
simultan
patient
clearli
bad
capac
make
ctl
respons
broad
rang
epitop
hiv
initi
respons
highli
foctis
singl
epitop
epitop
immunodomin
dictat
dnring
antivir
immun
respons
clear
level
present
differ
viral
epitop
avail
tcell
repertoir
impact
former
affect
epitop
process
peptid
transport
tbe
endoplasm
reticulum
tbe
bind
affin
peptid
class
molecul
stabihti
peptidemhc
complex
cell
surfac
ctl
epitop
overlap
differ
mhc
molecul
may
compet
present
tcell
repertoir
initi
determin
posit
neg
select
tbe
tbymu
subsequ
reshap
tbe
peripheri
cours
success
immun
respons
tbe
influenc
tbe
previou
infect
histori
may
subsequ
immun
respons
viru
infect
ba
illustr
mnrine
arenaviru
infect
hiv
patient
discuss
properti
epitop
sequenc
tcell
repertoir
time
infect
may
bave
contribut
extrem
immunodomin
earli
ctl
respons
tbe
gpl
peptid
may
advantag
potenti
epitop
sequenc
process
transport
appear
differ
process
transmembran
cytoplasm
protein
present
class
whicb
may
give
tbe
former
present
advantag
certain
circumst
interest
natur
process
signal
peptid
cleavag
occur
amino
acid
thu
gener
n
terminn
epitop
addit
epitop
predict
high
bind
affmiti
tcell
repertoir
effect
may
also
bave
play
role
possibl
tbat
prior
unrel
infect
patient
left
bim
popul
memori
cell
crossrecogn
epitop
cell
present
higher
frequenc
readili
activ
naiv
cell
domin
initi
immun
respons
demonstr
conclus
sampl
avail
tbi
patient
prior
infect
bowev
fact
epitopespecif
ctl
contain
ohgoclon
popul
vp
cell
underw
massiv
expans
earli
infect
patient
would
consist
anoth
studi
hiv
system
wbich
emphas
effect
escap
mutat
ctl
epitop
may
bave
ctl
specif
focus
ctl
respons
two
hlaident
hemophiliac
brother
expos
batch
contamin
factor
viii
becam
seroposit
within
week
one
anoth
ctl
respons
dissimilar
one
made
strong
respons
two
epitop
gag
whilst
instead
respond
two
hlab
ctl
epitop
mutat
botb
immunodomin
epitop
gag
respond
seen
provirai
sequenc
nonrespond
thu
hkeli
initi
made
ctl
respons
epitop
tbat
follow
emerg
escap
mutant
virus
tbi
respons
downregul
respons
stimul
individu
escap
mutant
virus
revert
index
sequenc
ctl
respons
diminish
impli
tbat
mutat
bore
detriment
viral
replic
case
howev
ctl
escap
mutat
may
reduc
viral
fit
impair
viru
replic
sever
tbey
select
first
place
may
contribut
fact
studi
escap
variant
seen
aris
particular
ctl
epitop
despit
fact
tbat
ctl
pressur
exert
long
period
time
smaller
impact
viral
fit
emerg
epitopespecif
ctl
exert
strong
pressur
viral
replic
overal
confer
advantag
viru
frequenc
epitopespecif
ctl
declin
tend
replac
viral
quasispeci
index
sequenc
fact
occur
hiv
patient
describ
strong
select
occur
tbe
viral
quasispeci
viral
variant
bear
mutat
residu
wbich
constitut
tbe
anchor
motif
ctl
epitop
domin
respons
made
tbe
earli
phase
infect
later
tbe
infect
wben
frequenc
epitopespecif
ctl
bad
declin
significandi
clone
bear
index
sequenc
began
emerg
tbe
viral
quasispeci
x
wei
p
borrow
epitop
immunodomin
mutant
viru
frequenc
tbu
drive
one
anoth
lead
complex
fluctuat
makeup
tbe
viral
quasispeci
ctl
specif
cours
persist
infect
sucb
fluctuat
observ
patient
cbronic
infect
mathemat
model
develop
describ
model
predict
tbat
antigen
variat
immunodomin
epitop
shift
respons
weaker
epitop
tberebi
reduc
immunolog
control
viru
certainli
occur
ba
illustr
experi
perform
lcmv
model
system
ctl
clone
direct
three
domin
epitop
recogn
antivir
ctl
respons
mice
use
select
vitro
lcmv
variant
bear
escapeconf
mutat
one
two
three
epitop
wben
mice
infect
tbe
mutant
virus
mount
ctl
respons
subdomin
epitop
includ
epitop
viral
polymeras
wbich
readili
appar
tbe
respons
wildtyp
viru
respons
driven
vitrogener
escap
viral
variant
control
viru
replic
less
effici
respons
wildtyp
viru
experi
indic
tbat
although
tbe
immnn
respons
extrem
plastic
capac
evolv
effici
contain
replic
escap
mutant
virus
may
limit
particularli
inbr
mice
divers
mhc
allel
restrict
outbr
human
popul
evolut
escap
viral
variant
may
thu
make
signific
contribut
viral
persist
infect
drive
suboptim
immun
respons
ctl
escap
viral
variant
emerg
must
tip
balanc
viru
replic
host
antivir
immun
respons
least
somewhat
favor
viru
replic
advantag
affect
cours
viru
infect
seen
tbe
experi
origin
demonstr
vivo
select
ctl
escap
viral
variant
lcmv
epitopespecif
tcr
transgen
mice
anim
develop
persist
infect
follow
inocnl
dose
virn
whicb
nontransgen
mice
rapidli
abl
clear
howev
tbi
system
tcr
repertoir
artifici
restrict
leav
open
question
whether
ctl
escap
viral
variant
may
also
biolog
signific
effect
cours
infect
natur
circumst
immun
system
capac
respond
mucb
broader
rang
viral
epitop
discuss
ctl
respons
may
coevolv
viral
quasispeci
mutat
affect
epitopespecif
ctl
lysi
vitro
bave
describ
number
differ
virus
like
signific
viru
infect
discnss
mous
hepat
virusstrain
jhm
mhvjhm
coronaviru
produc
acut
fatal
enceph
inbr
strain
mice
mice
infect
wbilst
suckl
dam
previous
immun
viru
tbey
protect
tbe
acut
encephahti
proport
mice
control
infect
major
develop
persist
infect
associ
chronic
demyelin
encephalomyehti
tbe
virusspecif
tcell
respons
import
control
infect
mice
direct
two
epitop
viral
surfac
gp
immunodomin
epitop
subdomin
epitop
recent
studi
show
mutat
caus
loss
recognit
present
tbe
immnnodomin
epitop
sequenc
almost
viru
sampl
symptomat
mice
tcell
epitop
mutat
epitop
detect
mice
witb
acut
enceph
whicb
die
soon
antivir
tcell
respons
mount
fonnd
low
frequenc
residu
viral
rna
central
nervou
system
anim
clear
infecti
viru
remain
asymptomat
late
time
infect
mhvjhm
variant
bear
mutat
epitop
isol
infect
mice
use
infect
naiv
mice
produc
increas
morbid
mortahti
thu
convinc
exampl
infect
wbicb
ctl
escap
variant
select
appear
key
factor
influenc
viru
pathogenesi
infect
may
repres
situat
host
abihti
control
viru
rephcat
tenuou
tcell
control
viru
replic
central
nervou
system
may
tbat
effici
rephc
advantag
confer
viru
escap
mutat
may
tip
balanc
firmli
favor
viru
ebv
human
gamma
herpesviru
carri
major
individu
hfelong
asymptomat
infect
oncogen
potenti
implic
pathogenesi
rang
malign
increas
risk
develop
ebvposit
mahgnanc
associ
immun
suppress
illustr
import
immun
control
maintain
nonpathogen
equilibrium
potenti
oncogen
virn
host
potent
antivir
ctl
respons
thought
play
import
role
control
viru
replic
spread
develop
diseas
abihti
tbi
viru
evad
clearanc
infect
host
attribut
number
differ
mechan
review
ctl
escap
variant
select
thought
play
major
role
unlik
tbe
virus
discuss
section
fbv
genet
stabl
dna
viru
mutat
whicb
may
confer
escap
prevail
host
ctl
respons
tbu
hkeli
aris
infrequ
escap
variant
gener
select
constitut
effici
mean
ofimmun
evas
within
given
host
mutat
document
viru
popul
prevaihng
certain
area
wbich
confer
escap
recognit
ctl
direct
epitop
whicb
present
hla
allel
possess
high
proport
local
populac
tbe
best
known
exampl
involv
restrict
ctl
epitop
protein
conserv
tbe
major
type
ebv
isol
caucasian
african
popul
hlaa
allel
frequenc
low
mutat
virtual
isol
highli
allposit
immunologicoj
review
popul
china
coastal
new
guinea
major
mutat
locat
within
anchor
residu
abrog
epitop
bind
hlaal
molecul
discuss
earher
mutat
would
provid
escap
epilopespecif
ctl
regardless
tcr
usag
suggest
may
confer
select
advantag
viru
posit
popul
isol
howev
fbv
isol
southeast
asia
differ
caucasian
african
isol
number
loci
polymorph
shown
affect
antigen
epitop
present
high
frequenc
southeast
asian
popul
rais
possibl
chang
observ
al
epitop
may
coincident
support
hypothesi
specif
epitop
loss
obtain
ebv
isol
highli
african
popul
sequenc
across
epitopecontain
region
protein
howev
frequenc
popul
half
frequenc
southeast
asian
popul
epitop
mutat
detect
ctl
respons
ebv
usual
strong
restrict
hlaa
whether
ebvspecif
ctl
respons
fact
select
viral
variant
growth
advantag
within
human
popul
bear
certain
hla
allel
thn
remain
unresolv
issu
hbv
hepadnaviru
although
dna
genom
replic
via
revers
transcript
pregenom
rna
thu
high
mutat
rate
viru
produc
acut
chronic
infect
man
ctl
respons
play
key
role
viru
clearanc
pathogenesi
associ
liver
diseas
acut
hbv
infect
patient
develop
strong
polyclon
ctl
respons
multipl
epitop
differ
viral
protein
discuss
likelihood
select
escap
mutant
virus
condit
prohabl
low
mutat
provid
escap
ctl
singl
specif
may
confer
signific
select
advantag
viru
bear
presenc
strong
ctl
respons
mani
epitop
contrast
ctl
respons
usual
much
weaker
chronic
hbv
infect
patient
may
also
ohgospecif
provid
greater
opportun
select
epitopespecif
escap
mutat
inde
one
report
two
patient
show
strong
ctl
respons
narrowli
focus
epitop
hbv
core
protein
amino
acid
fail
respond
ctl
epitop
hbv
frequent
recogn
acut
infect
patient
persist
viru
patient
sequenc
quasispeci
found
domin
variant
viru
carri
mutat
within
hbv
core
epitop
affect
epitop
recognit
patient
ctl
could
antagon
respons
certain
ctl
clone
index
epitop
although
convers
wildtyp
mutant
sequenc
demonstr
patient
like
repres
exampl
escap
variant
select
strong
epitopespecif
ctl
respons
ctl
respons
restrict
hla
allel
analyz
patient
inform
avail
ctl
repertoir
may
evolv
respons
emerg
mutant
virus
thu
difficult
assess
escap
variant
may
impact
overal
effici
ctlmediat
control
viru
rephcat
individu
report
suggest
emerg
viru
variant
bear
ctl
escap
mutat
may
common
event
chronic
hepat
b
infect
escap
mutat
identifi
stndi
ctl
respons
eight
differ
epitop
defin
patient
acut
hbv
infect
sequenc
region
vivo
viral
quasispeci
analyz
parallel
patient
chronic
infect
hbv
virusspecif
ctl
respons
undetect
eight
patient
weak
four
ctlmediat
pressur
may
thu
low
select
escap
variant
whether
select
escap
mutat
play
critic
role
hbv
persist
thu
question
like
develop
weak
antivir
immun
respons
ol
much
greater
import
determin
cours
infect
hcv
positivestrand
rna
viru
assign
new
genu
flavivirida
well
adapt
persist
human
host
least
infect
individu
develop
chronic
infect
frequent
associ
clinic
hepat
hbv
infect
virusspecif
cd
ctl
respons
thought
play
import
role
limit
viru
replic
simultan
contribut
diseas
pathogenesi
howev
unlik
situat
hbv
infect
cellmedi
immun
respons
viru
gener
lowundetect
chronic
infect
individu
hcv
persist
presenc
strong
virusspecif
ctl
respons
observ
human
experiment
infect
chimpanze
review
highli
mutabl
natur
viru
rna
genom
rais
possibl
antigen
variat
may
one
mechan
via
aciiiev
persist
face
antivirai
immun
respons
inde
one
report
chimpanze
becam
persistentiy
infect
hcv
tiie
virai
quasispeci
underw
compiet
repiac
virai
variant
hear
conserv
amino
acid
suhstitut
residu
epitop
nonstructur
protein
recogn
hy
iiverderiv
ctl
iin
anim
mutat
ahrog
recognit
epitop
animai
ctl
ctl
respons
animai
recogn
epitop
mtiltipi
virai
protein
ioo
whetiier
mutat
seiect
epitop
epitop
specificityimmunodomin
may
iiav
ciiang
cours
infect
respons
virai
variat
impact
escap
variant
seiection
may
overali
effici
controi
viru
repiic
determin
howev
tiii
studi
iliustr
even
though
ctl
respons
hcv
frequentiy
poiycionai
escap
virai
variant
seiect
hcv
infect
discuss
beiow
hiv
inform
ahout
coevoiut
virai
quasispeci
tiie
immun
respons
avaiiahi
escap
mutat
iikeiy
compromis
immun
control
hcv
infect
probabiy
one
factor
contrihut
persist
viru
human
host
hiv
ehcit
strong
ctl
respons
infect
individu
eariy
ctl
respons
tempor
coincid
reduct
acut
plasma
viremia
discuss
ahov
virusspecif
ctl
iikeiy
expand
extremeiy
iiigh
frequenc
primari
immun
respons
frequenc
virusspecif
ctl
deciin
somewhat
howev
high
ievei
activ
ctl
commoniy
detect
chronicaiiy
infect
asymptomat
individuai
even
set
extremeiy
iow
virai
ioad
diseas
progress
occur
virusspecif
ctl
frequenc
may
initialiy
increas
respons
increas
viral
ioad
generaili
faii
imdetectabi
ievei
end
stage
infect
number
hne
direct
indirect
evid
discuss
indic
ctl
respons
piay
import
role
controii
viru
repiic
infect
individuai
varieti
mechan
propos
contribut
viru
persist
face
host
immun
respons
focu
role
select
ctl
escap
viru
variant
may
piay
infect
high
virai
turnov
infect
rapid
mutat
rate
viru
strong
virusspecif
ctl
respons
provid
condit
ctl
escap
mutant
wouid
iikeiy
emerg
inde
indic
earher
numer
report
variant
virus
within
quasispeci
differ
patient
abl
escap
recognit
epitopespecif
ctl
escap
viru
variant
may
select
differ
stage
infect
correspondingli
impact
virushost
baianc
differ
way
primari
infect
viru
undergo
intens
hurst
rephcat
ctl
direct
domin
epitop
may
reach
extremeiy
high
frequenc
escap
variant
seiection
may
particuiariy
favor
observ
repiac
virai
quasispeci
hy
variant
mutat
epitop
target
tiie
primari
ctl
respons
eariy
stage
infect
two
patient
anaiyz
aiso
anoth
studi
document
ctl
escap
variant
emerg
seroconvert
interestingli
two
patient
observ
eariy
seiection
ctl
escap
variant
virus
botii
underw
rapid
diseas
progress
studi
larger
number
patient
requir
reveai
frequentiy
eariy
seiection
mutat
epitop
recogn
primari
ctl
respons
fact
occur
whether
phenomenon
aiway
associ
rapid
progress
aid
emerg
virai
variant
mutat
confer
resist
controi
domin
ctl
respons
eariy
stage
infect
may
potentialiy
impact
suhsequ
cours
infect
two
way
first
virai
variant
wiii
oniy
seiect
rephc
advantag
emerg
ctl
escap
variant
must
associ
increas
eariy
viru
rephcat
spread
consequ
may
inciud
increas
ioss
cell
estabhsh
lareo
er
pooi
iatentiy
infect
ceii
higiier
setpoint
ievei
persist
viru
iatter
demonstr
good
predictor
subsequ
rate
diseas
progress
second
discuss
mutat
immunodomin
ctl
epitop
may
promot
evoiut
immun
respons
recogn
subdomin
epitop
host
may
left
tiie
acut
phase
infect
oniy
higher
ievei
persist
viru
aiso
ctl
respons
iess
adequ
contain
midhiv
infect
mutat
affect
recognit
epitopespecif
ctl
demonstr
persist
virai
quasispeci
numher
studi
eg
howev
clear
exampl
variant
select
fix
virai
quasispeci
time
difficuit
find
hkeiy
hecaus
ctl
respons
muitipi
virai
epitop
frequendi
present
discuss
earher
condit
complex
cyci
fluctuat
domin
ctl
respons
direct
differ
viral
epitop
correspond
shift
epitop
composit
viral
quasispeci
may
occur
also
exampl
strong
ctl
respons
exhibit
long
period
time
absenc
appear
mutat
epitop
direct
ctl
epitop
mutat
chronic
hiv
infect
tbu
seem
essenti
continu
persist
viru
howev
occnr
may
allow
higher
level
viru
replic
benc
promot
diseas
progress
later
stage
infect
immun
system
fail
impact
viral
variat
immun
control
may
becom
pronounc
capac
immun
respons
evolv
focu
tmmutat
epitop
escap
variant
select
may
limit
time
simultan
rehanc
host
ctl
lysi
mean
control
viru
replic
spread
may
increas
particularli
syncytiuminduc
virus
resist
control
chemokin
rant
miela
appear
ctl
escap
variant
may
thu
grow
contribut
tbe
escal
viremia
recent
paper
describ
two
exampl
patient
mutat
confer
evas
previous
stabl
immunodomin
ctl
respons
becam
fix
viral
quasispeci
late
stage
infect
provid
clear
illustr
tbi
occur
ctl
escap
viral
variant
may
thu
influenc
immun
system
abihti
control
viru
replic
stage
hiv
infect
like
bave
import
impact
overal
diseas
cours
least
proport
infect
individu
preced
discuss
illustr
tbat
viral
variant
whicb
abl
escap
recognit
host
ctl
emerg
number
differ
viru
infect
clearli
biolog
signific
impact
tbe
balanc
viru
replic
control
immun
respons
least
case
latter
includ
sever
infect
clinic
signific
human
thu
import
immunebas
propbylact
therapeut
strategi
combat
infect
design
minim
likelihood
ctl
escap
variant
select
exampl
literatur
prophylact
therapeut
strategi
wbich
led
select
viral
variant
abl
escap
recognit
ctl
respons
wbich
intend
mediat
benefici
effect
describ
review
studi
human
viru
infect
murin
model
system
illustr
condit
ctl
escap
viral
variant
like
emerg
inform
consid
futur
vaccinetherapi
design
prevent
similar
outcom
occur
given
escapeconf
mutat
select
detriment
effect
viru
replic
escap
mutat
emerg
rapidli
wben
ctl
pressur
predominantli
focus
onto
singl
bighli
immunodomin
epitop
vaccin
aim
induc
broad
immun
respons
recogn
multipl
codomin
viral
epitop
least
lie
conserv
region
viral
protein
stringent
function
constraint
eeptid
minigenebas
vaccin
strategi
probabl
optim
choic
use
infect
even
includ
care
chosen
cocktail
epitop
recogn
associ
multipl
hla
allel
bigh
probabl
induc
monoor
oligospecif
immun
respons
individu
certain
hla
type
particularli
infect
viru
show
sequenc
variat
compar
antigen
use
vaccin
danger
vaccin
might
prime
immun
respons
could
detriment
immun
respons
may
ehcit
natur
follow
infect
vaccin
inclnd
multipl
viral
antigen
preferenti
immunogen
induct
benefici
multispecif
antivir
immun
respons
